AIAISci
中文

Science community intelligence

Biotech science

Biotech league updates across protein design, genomics, cell systems, diagnostics, clinical signals, and biomanufacturing.

Reviewed signals
601
Evidence sources
721
Tracked fields
6
Biotech leagueDiagnostics and Biomarkers93 matching updates
publicationBiotecheditor reviewed
Rising signal69

Immunohistochemical and Molecular Biomarkers Bridging Pathogenesis and Precision Medicine in Endometrial Carcinoma: A Systematic Review

Publication signal: Immunohistochemical and Molecular Biomarkers Bridging Pathogenesis and Precision Medicine in Endometrial Carcinoma: A Systematic Review

Verified by AIScieditor reviewed / 1 evidence source
Diagnostics and Biomarkers
1 evidence source
Source 1: Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences)
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal62

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Clinical/translation signal: A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal62

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Clinical/translation signal: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
publicationBiotecheditor reviewed
Rising signal62

Emerging Biomarkers in Pediatric Food Allergy: From Mechanistic Endotyping to Precision Diagnosis and Therapeutic Monitoring

Publication signal: Emerging Biomarkers in Pediatric Food Allergy: From Mechanistic Endotyping to Precision Diagnosis and Therapeutic Monitoring

Verified by AIScieditor reviewed / 1 evidence source
Diagnostics and Biomarkers
1 evidence source
Source 1: Multidisciplinary Digital Publishing Institute
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal60

Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

Clinical/translation signal: Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
publicationBiotecheditor reviewed
Rising signal60

Next-Generation Cardiovascular Imaging in Precision Medicine: Integrating Functional Imaging, Artificial Intelligence, Biomarkers, and Personalized Risk Stratification

Publication signal: Next-Generation Cardiovascular Imaging in Precision Medicine: Integrating Functional Imaging, Artificial Intelligence, Biomarkers, and Personalized Risk Stratification

Verified by AIScieditor reviewed / 1 evidence source
Diagnostics and Biomarkers
1 evidence source
Source 1: MDPI AG
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal60

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Clinical/translation signal: Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal60

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Clinical/translation signal: Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
publicationBiotecheditor reviewed
Rising signal60

Application of Epigenetic biomarkers in the precision medicine for sepsis-induced acute lung injury: From risk stratification to targeted therapy

Publication signal: Application of Epigenetic biomarkers in the precision medicine for sepsis-induced acute lung injury: From risk stratification to targeted therapy

Verified by AIScieditor reviewed / 1 evidence source
Diagnostics and Biomarkers
1 evidence source
Source 1: Cell Press
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal59

More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)

Clinical/translation signal: More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal59

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Clinical/translation signal: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal59

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Clinical/translation signal: Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal59

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

Clinical/translation signal: Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal58

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Clinical/translation signal: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context
clinical updateBiotecheditor reviewed
Rising signal58

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Clinical/translation signal: PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Verified by AIScieditor reviewed / 1 evidence source
Organizations
Diagnostics and Biomarkers
1 evidence source
Source 1: ClinicalTrials.gov
Open paper workspaceOpen graph context